Steven Pogwizd is a Cardiology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 147 publications with 7,423 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Provider last certified this registry record 4 Jun 2025.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.4%Beta blocker15.6%Metoprolol Succinate46%Metoprolol Tartrate28%Carvedilol26%Part D≥32 patientsNitrate7.7%Isosorbide Mononitrate Er68%Nitroglycerin17%Isosorbide Dinitrate15%Part D<11 patients+ 12 more classes in this area
Blood & clotting
15.9%Factor Xa inhibitor15%Eliquis85%Xarelto15%Part D<11 patientsP2Y12 inhibitor1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
12.7%SGLT2 inhibitor12.7%Jardiance90%Farxiga10%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2010 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Trials and tribulations of cell therapy for heart failure: an update on ongoing trials
Nature Reviews Cardiology
2024 - Racial and socioeconomic disparity associates with differences in cardiac DNA methylation among men with end-stage heart failure
American Journal of Physiology-Heart and Circulatory Physiology
2021 - Progressive cardiac arrhythmias and ECG abnormalities in the Huntington’s disease BACHD mouse model
Human Molecular Genetics
2019 - Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure
Laboratory Investigation
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”